What monophasic combined oral contraceptive regimen is recommended for a healthy, non‑pregnant, non‑breastfeeding adult woman of reproductive age without contraindications?

Monophasic Combined Oral Contraceptive Regimen

For a healthy woman of reproductive age without contraindications, prescribe a monophasic combined oral contraceptive containing both estrogen and progestin, taken for 21-24 consecutive days followed by 4-7 hormone-free days. 1

Standard Regimen Components

Monophasic formulations provide the same dose of estrogen and progestin daily throughout the active pill cycle, distinguishing them from multiphasic preparations that vary hormone doses. 2 The CDC guidelines establish that combined hormonal contraceptives are reversible, can be used by women of all ages, and result in approximately 9 out of 100 women becoming pregnant in the first year with typical use. 1

Dosing Schedule Options

• 21/7 regimen: 21 days of active hormonal pills followed by 7 hormone-free days (placebo or no pills) 1
• 24/4 regimen: 24 days of active hormonal pills followed by 4 hormone-free days 1

The 24/4 regimen demonstrates greater inhibition of follicular growth and shorter withdrawal bleeding duration compared to the 21/7 regimen, suggesting improved contraceptive efficacy margin. 3

Initiation Protocol

Start combined hormonal contraceptives at any time if reasonably certain the woman is not pregnant. 1, 4

Backup Contraception Requirements

• If started within the first 5 days of menstrual bleeding: No additional contraceptive protection needed 1, 4
• If started >5 days after menstrual bleeding began: Abstain from intercourse or use barrier methods for 7 consecutive days 1, 4

Required Pre-Initiation Assessment

Blood pressure measurement is the only examination required before initiating combined hormonal contraceptives. 4 Weight measurement is not needed to determine medical eligibility, though baseline BMI may be helpful for monitoring. 4

Monophasic vs. Multiphasic Formulations

Monophasic pills are recommended as first choice for women starting oral contraceptive use. 5 A Cochrane systematic review of 23 trials found no significant differences between triphasic and monophasic preparations in contraceptive effectiveness, discontinuation rates, or overall bleeding patterns. 5 The available evidence is insufficient to demonstrate superiority of triphasic formulations. 5

Missed Dose Management

One Missed Pill (<48 hours late)

• Take the missed pill as soon as possible 6
• Continue remaining pills at usual time (may require two pills in one day) 6
• No backup contraception needed 6
• Emergency contraception not usually needed 6

Two or More Missed Pills (≥48 hours late)

• Take the most recent missed pill immediately; discard other missed pills 6
• Continue remaining pills at usual time 6
• Use backup contraception for 7 consecutive days 6
• If missed pills occurred in the last week of active pills (days 15-21 of 28-day pack): Omit the hormone-free interval and start a new pack immediately 6
• Consider emergency contraception if unprotected intercourse occurred in previous 5 days and pills were missed in first week of pack 6

Special Considerations

Postpartum Non-Breastfeeding Women

• Do not use combined hormonal contraceptives during first 3 weeks postpartum (U.S. MEC Category 4) due to venous thromboembolism risk 1
• Women with additional VTE risk factors should generally not use combined hormonal contraceptives 3-6 weeks postpartum (U.S. MEC Category 3) 1

Postpartum Breastfeeding Women

• Do not use during first 3 weeks postpartum (U.S. MEC Category 4) 1
• Generally should not use during fourth week postpartum (U.S. MEC Category 3) due to potential effects on breastfeeding performance 1

Post-Abortion

• Can be started within first 7 days after first or second trimester abortion, including immediately post-abortion (U.S. MEC Category 1) 1
• Requires 7 days backup contraception unless started at time of surgical abortion 1

Important Caveats

Combined hormonal contraceptives do not protect against sexually transmitted infections; consistent condom use is necessary for STI/HIV prevention. 1

Smoking status significantly affects safety: Women ≥35 years who smoke ≥15 cigarettes daily should not use combined oral contraceptives (Category 4) due to unacceptable cardiovascular risk. 7